Skip to main content
Erschienen in:

31.03.2021 | Review Article

Incidental Gallbladder Cancer—Current Recommendations and Management Protocols

verfasst von: Vikram A. Chaudhari, Manish S. Bhandare, Shailesh V. Shrikhande

Erschienen in: Indian Journal of Surgery | Sonderheft 4/2021

Einloggen, um Zugang zu erhalten

Abstract

The term “incidental gallbladder cancer” (IGBC) includes patients detected during or after cholecystectomy as an intraoperative or histological surprise. Overall, 0.25–3.0% of patients undergoing laparoscopic cholecystectomy will be incidentally detected to harbor GBC. Aggressive re-resection with or without systemic therapy offers the only chance for cure. Patients should undergo thorough staging assessment prior to re-resection. All resectable patients with pTb disease and beyond should be offered revision surgery. Timing of surgery, role of minimally invasive surgery, radiotherapy, and neoadjuvant chemotherapy in IGBC are still being evaluated and await further evidence. Minimally invasive surgery for IGBC is technically feasible however it is not recommended as a routine. Adjuvant chemotherapy is recommended in patients with pT2 disease and beyond and node-positive status. Margin-positive patients may benefit with adjuvant radiation in addition to chemotherapy. Neoadjuvant therapy in IGBC is evolving and selective use in high-risk patients (T3, T4, N1) should be considered in the setting of a clinical study.
Literatur
3.
Zurück zum Zitat Konstantinidis IT, Deshpande V, Genevay M, Berger D, Fernandez-del Castillo C, Tanabe KK, Zheng H, Lauwers GY, Ferrone CR (2009) Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg 144(5):441–447; discussion 447. https://doi.org/10.1001/archsurg.2009.46CrossRefPubMed Konstantinidis IT, Deshpande V, Genevay M, Berger D, Fernandez-del Castillo C, Tanabe KK, Zheng H, Lauwers GY, Ferrone CR (2009) Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg 144(5):441–447; discussion 447. https://​doi.​org/​10.​1001/​archsurg.​2009.​46CrossRefPubMed
8.
Zurück zum Zitat Patkar S, Ostwal V, Ramaswamy A, Engineer R, Chopra S, Shetty N, Dusane R, Shrikhande SV, Goel M (2018) Emerging role of multimodality treatment in gall bladder cancer: outcomes following 510 consecutive resections in a tertiary referral center. J Surg Oncol 117(3):372–379. https://doi.org/10.1002/jso.24837CrossRefPubMed Patkar S, Ostwal V, Ramaswamy A, Engineer R, Chopra S, Shetty N, Dusane R, Shrikhande SV, Goel M (2018) Emerging role of multimodality treatment in gall bladder cancer: outcomes following 510 consecutive resections in a tertiary referral center. J Surg Oncol 117(3):372–379. https://​doi.​org/​10.​1002/​jso.​24837CrossRefPubMed
9.
17.
Zurück zum Zitat Pawlik TM, Gleisner AL, Vigano L, Kooby DA, Bauer TW, Frilling A, Adams RB, Staley CA, Trindade EN, Schulick RD, Choti MA, Capussotti L (2007) Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg 11(11):1478–1486; discussion 1486-7. https://doi.org/10.1007/s11605-007-0309-6CrossRefPubMed Pawlik TM, Gleisner AL, Vigano L, Kooby DA, Bauer TW, Frilling A, Adams RB, Staley CA, Trindade EN, Schulick RD, Choti MA, Capussotti L (2007) Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg 11(11):1478–1486; discussion 1486-7. https://​doi.​org/​10.​1007/​s11605-007-0309-6CrossRefPubMed
20.
Zurück zum Zitat Ethun CG, Postlewait LM, Le N, Pawlik TM, Buettner S, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Jin LX, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Kooby DA, Maithel SK (2017) Association of optimal time interval to re-resection for incidental gallbladder cancer with overall survival: a multi-institution analysis from the US extrahepatic biliary malignancy consortium. JAMA Surg 152(2):143–149. https://doi.org/10.1001/jamasurg.2016.3642CrossRefPubMedPubMedCentral Ethun CG, Postlewait LM, Le N, Pawlik TM, Buettner S, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Jin LX, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Kooby DA, Maithel SK (2017) Association of optimal time interval to re-resection for incidental gallbladder cancer with overall survival: a multi-institution analysis from the US extrahepatic biliary malignancy consortium. JAMA Surg 152(2):143–149. https://​doi.​org/​10.​1001/​jamasurg.​2016.​3642CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Kim JH, Kim TK, Eun HW, Kim BS, Lee MG, Kim PN, Ha HK (2002) Preoperative evaluation of gallbladder carcinoma: efficacy of combined use of MR imaging, MR cholangiography, and contrast-enhanced dual-phase three-dimensional MR angiography. J Magn Reson Imaging 16(6):676–684. https://doi.org/10.1002/jmri.10212CrossRefPubMed Kim JH, Kim TK, Eun HW, Kim BS, Lee MG, Kim PN, Ha HK (2002) Preoperative evaluation of gallbladder carcinoma: efficacy of combined use of MR imaging, MR cholangiography, and contrast-enhanced dual-phase three-dimensional MR angiography. J Magn Reson Imaging 16(6):676–684. https://​doi.​org/​10.​1002/​jmri.​10212CrossRefPubMed
30.
Zurück zum Zitat Goere D, Wagholikar GD, Pessaux P, Carrère N, Sibert A, Vilgrain V, Sauvanet A, Belghiti J (2006) Utility of staging laparoscopy in subsets of biliary cancers : laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc 20(5):721–725. https://doi.org/10.1007/s00464-005-0583-xCrossRefPubMed Goere D, Wagholikar GD, Pessaux P, Carrère N, Sibert A, Vilgrain V, Sauvanet A, Belghiti J (2006) Utility of staging laparoscopy in subsets of biliary cancers : laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc 20(5):721–725. https://​doi.​org/​10.​1007/​s00464-005-0583-xCrossRefPubMed
38.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC (2010) AJCC cancer staging manual, 7th edn. Springer, New York, NY, pp 211–217 Edge SB, Byrd DR, Compton CC (2010) AJCC cancer staging manual, 7th edn. Springer, New York, NY, pp 211–217
39.
Zurück zum Zitat Amin, M.B., Edge, S., Greene, F. Byrd, D.R., Brookland, R.K., Washington, M.K., et al. AJCC cancer staging manual (8th edition). Amin, M.B., Edge, S., Greene, F. Byrd, D.R., Brookland, R.K., Washington, M.K., et al. AJCC cancer staging manual (8th edition).
44.
Zurück zum Zitat Fuks D, Regimbeau JM, Pessaux P, Bachellier P, Raventos A, Mantion G, Gigot JF, Chiche L, Pascal G, Azoulay D, Laurent A, Letoublon C, Boleslawski E, Rivoire M, Mabrut JY, Adham M, Le Treut YP, Delpero JR, Navarro F, Ayav A, Boudjema K, Nuzzo G, Scotte M, Farges O (2013) Is port-site resection necessary in the surgical management of gallbladder cancer? J Visc Surg 150(4):277–284. https://doi.org/10.1016/j.jviscsurg.2013.03.006CrossRefPubMed Fuks D, Regimbeau JM, Pessaux P, Bachellier P, Raventos A, Mantion G, Gigot JF, Chiche L, Pascal G, Azoulay D, Laurent A, Letoublon C, Boleslawski E, Rivoire M, Mabrut JY, Adham M, Le Treut YP, Delpero JR, Navarro F, Ayav A, Boudjema K, Nuzzo G, Scotte M, Farges O (2013) Is port-site resection necessary in the surgical management of gallbladder cancer? J Visc Surg 150(4):277–284. https://​doi.​org/​10.​1016/​j.​jviscsurg.​2013.​03.​006CrossRefPubMed
48.
Zurück zum Zitat Agarwal AK, Javed A, Kalayarasan R, Sakhuja P (2015) Minimally invasive versus the conventional open surgical approach of a radical cholecystectomy for gallbladder cancer: a retrospective comparative study. HPB (Oxford) 17(6):536–541. https://doi.org/10.1111/hpb.12406CrossRef Agarwal AK, Javed A, Kalayarasan R, Sakhuja P (2015) Minimally invasive versus the conventional open surgical approach of a radical cholecystectomy for gallbladder cancer: a retrospective comparative study. HPB (Oxford) 17(6):536–541. https://​doi.​org/​10.​1111/​hpb.​12406CrossRef
53.
Zurück zum Zitat Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M (2010) Bridgewater J; ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14):1273–1281. https://doi.org/10.1056/NEJMoa0908721CrossRefPubMed Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M (2010) Bridgewater J; ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14):1273–1281. https://​doi.​org/​10.​1056/​NEJMoa0908721CrossRefPubMed
54.
Zurück zum Zitat Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T (2002) Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 95(8):1685–1695. https://doi.org/10.1002/cncr.10831CrossRefPubMed Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T (2002) Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 95(8):1685–1695. https://​doi.​org/​10.​1002/​cncr.​10831CrossRefPubMed
60.
Zurück zum Zitat Goetze TO, Bechstein WO, Bankstahl US, Keck T, Königsrainer A, Lang SA, Pauligk C, Piso P, Vogel A, Al-Batran SE (2020) Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial. BMC Cancer 20(1):122. https://doi.org/10.1186/s12885-020-6610-4CrossRefPubMedPubMedCentral Goetze TO, Bechstein WO, Bankstahl US, Keck T, Königsrainer A, Lang SA, Pauligk C, Piso P, Vogel A, Al-Batran SE (2020) Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial. BMC Cancer 20(1):122. https://​doi.​org/​10.​1186/​s12885-020-6610-4CrossRefPubMedPubMedCentral
61.
Zurück zum Zitat Iyer P, Shrikhande SV, Ranjan M, Joshi A, Gardi N, Prasad R, Dharavath B, Thorat R, Salunkhe S, Sahoo B, Chandrani P, Kore H, Mohanty B, Chaudhari V, Choughule A, Kawle D, Chaudhari P, Ingle A, Banavali S, Gera P, Ramadwar MR, Prabhash K, Barreto SG, Dutt S, Dutt A (2018) ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer. Int J Cancer 144:2008–2019. https://doi.org/10.1002/ijc.31916CrossRefPubMedPubMedCentral Iyer P, Shrikhande SV, Ranjan M, Joshi A, Gardi N, Prasad R, Dharavath B, Thorat R, Salunkhe S, Sahoo B, Chandrani P, Kore H, Mohanty B, Chaudhari V, Choughule A, Kawle D, Chaudhari P, Ingle A, Banavali S, Gera P, Ramadwar MR, Prabhash K, Barreto SG, Dutt S, Dutt A (2018) ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer. Int J Cancer 144:2008–2019. https://​doi.​org/​10.​1002/​ijc.​31916CrossRefPubMedPubMedCentral
65.
Zurück zum Zitat Lee SE, Jang JY, Kim SW, Han HS, Kim HJ, Yun SS, Cho BH, Yu HC, Lee WJ, Yoon DS, Choi DW, Choi SH, Hong SC, Lee SM, Kim HJ, Choi IS, Song IS, Park SJ (2014) Jo S; Korean Pancreas Surgery Club. Surgical strategy for T1 gallbladder cancer: a nationwide multicenter survey in South Korea. Ann Surg Oncol 21(11):3654–3660. https://doi.org/10.1245/s10434-014-3527-7CrossRefPubMed Lee SE, Jang JY, Kim SW, Han HS, Kim HJ, Yun SS, Cho BH, Yu HC, Lee WJ, Yoon DS, Choi DW, Choi SH, Hong SC, Lee SM, Kim HJ, Choi IS, Song IS, Park SJ (2014) Jo S; Korean Pancreas Surgery Club. Surgical strategy for T1 gallbladder cancer: a nationwide multicenter survey in South Korea. Ann Surg Oncol 21(11):3654–3660. https://​doi.​org/​10.​1245/​s10434-014-3527-7CrossRefPubMed
66.
Zurück zum Zitat Ouchi K, Mikuni J, Kakugawa Y (2002) Organizing Committee, The 30th Annual Congress of the Japanese Society of Biliary Surgery. Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. J Hepato-Biliary-Pancreat Surg 9(2):256–260. https://doi.org/10.1007/s005340200028CrossRef Ouchi K, Mikuni J, Kakugawa Y (2002) Organizing Committee, The 30th Annual Congress of the Japanese Society of Biliary Surgery. Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. J Hepato-Biliary-Pancreat Surg 9(2):256–260. https://​doi.​org/​10.​1007/​s005340200028CrossRef
Metadaten
Titel
Incidental Gallbladder Cancer—Current Recommendations and Management Protocols
verfasst von
Vikram A. Chaudhari
Manish S. Bhandare
Shailesh V. Shrikhande
Publikationsdatum
31.03.2021
Verlag
Springer India
Erschienen in
Indian Journal of Surgery / Ausgabe Sonderheft 4/2021
Print ISSN: 0972-2068
Elektronische ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-021-02828-9

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" sprechen Prof. Dr. Leila Harhaus-Wähner und Ressortleiter Dr. Gunter Freese im WebTalk Leitlinie KOMPAKT, einer neuen Webcast-Serie von SpringerMedizin passend zu Ihrem Fachmagazin Orthopädie und Unfallchirurgie Mitteilungen und Nachrichten. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.